Stayble Therapeutics AB (publ) (STABL.ST)

SEK 0.39

(1.56%)

Total Debt Summary of Stayble Therapeutics AB (publ)

  • Stayble Therapeutics AB (publ)'s latest annual total debt in 2023 was 850 Thousand SEK , down 0.0% from previous year.
  • Stayble Therapeutics AB (publ)'s latest quarterly total debt in 2024 Q2 was 850 Thousand SEK , down 0.0% from previous quarter.
  • Stayble Therapeutics AB (publ) reported annual total debt of 850 Thousand SEK in 2022, down 0.0% from previous year.
  • Stayble Therapeutics AB (publ) reported annual total debt of 850 Thousand SEK in 2021, down 0.0% from previous year.
  • Stayble Therapeutics AB (publ) reported quarterly total debt of 850 Thousand SEK for 2024 Q1, down 0.0% from previous quarter.
  • Stayble Therapeutics AB (publ) reported quarterly total debt of 850 Thousand SEK for 2023 FY, down 0.0% from previous quarter.

Annual Total Debt Chart of Stayble Therapeutics AB (publ) (2023 - 2016)

Historical Annual Total Debt of Stayble Therapeutics AB (publ) (2023 - 2016)

Year Total Debt Total Debt Growth
2023 850 Thousand SEK 0.0%
2022 850 Thousand SEK 0.0%
2021 850 Thousand SEK 0.0%
2020 850 Thousand SEK -37.04%
2019 1.35 Million SEK 58.82%
2018 850 Thousand SEK 0.0%
2017 850 Thousand SEK 0.0%
2016 850 Thousand SEK 0.0%

Peer Total Debt Comparison of Stayble Therapeutics AB (publ)

Name Total Debt Total Debt Difference
Alligator Bioscience AB (publ) 16.09 Million SEK 94.72%
Ziccum AB (publ) 857 Thousand SEK 0.817%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 4.97 Million SEK 82.928%
Sprint Bioscience AB (publ) - SEK -Infinity%
Mendus AB (publ) 24.48 Million SEK 96.529%
Genovis AB (publ.) 79.32 Million SEK 98.928%
Intervacc AB (publ) 181 Thousand SEK -369.613%
QuiaPEG Pharmaceuticals Holding AB (publ) 20.61 Million SEK 95.876%
Active Biotech AB (publ) 3 Million SEK 71.667%
Magle Chemoswed Holding AB (publ) 60.3 Million SEK 98.59%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) 5 Million SEK 83.0%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Kancera AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Saniona AB (publ) 71.4 Million SEK 98.81%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Biovica International AB (publ) 7.82 Million SEK 89.142%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -100.472%
Egetis Therapeutics AB (publ) 108.6 Million SEK 99.217%
Karolinska Development AB (publ) 3.07 Million SEK 72.313%
OncoZenge AB (publ) - SEK -Infinity%
Amniotics AB (publ) 2.58 Million SEK 67.054%
2cureX AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK 15.0%
Calliditas Therapeutics AB (publ) 979.13 Million SEK 99.913%
Camurus AB (publ) 24.5 Million SEK 96.532%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 27.56 Million SEK 96.916%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 866.76 Million SEK 99.902%
Cyxone AB (publ) 858 Thousand SEK 0.932%
ExpreS2ion Biotech Holding AB (publ) 1.71 Million SEK 50.321%
Biosergen AB - SEK -Infinity%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Xspray Pharma AB (publ) 36.8 Million SEK 97.691%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Nanologica AB (publ) 666 Thousand SEK -27.628%
SynAct Pharma AB 637 Thousand SEK -33.438%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
LIDDS AB (publ) - SEK -Infinity%
Lipum AB (publ) 1.76 Million SEK 51.732%
BioInvent International AB (publ) 23.24 Million SEK 96.343%
Alzinova AB (publ) 800 Thousand SEK -6.25%
Oncopeptides AB (publ) 106.48 Million SEK 99.202%
Pila Pharma AB (publ) 773.08 Thousand SEK -9.95%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 99.063%
Diamyd Medical AB (publ) 30.67 Million SEK 97.229%
Xbrane Biopharma AB (publ) 231.47 Million SEK 99.633%
Ascelia Pharma AB (publ) 1.06 Million SEK 19.887%
Diagonal Bio AB (publ) - SEK -Infinity%